Peptide therapy is generally not appropriate for patients who are pregnant, breastfeeding, have active hormone-sensitive cancers, or uncontrolled autoimmune conditions
BCP 157 (0.01 and 10 g/kg, i.p.) decreases the duration of catalepsy and reduces tremor severity in a mouse model of Parkinson's disease induced by MPTP.Formal Name: glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglycyl-L-leucyl-L-valine, acetate
This includes TB-500 10mg, BPC-157 10mg, all ipamorelin formats (5mg and 10mg), all CJC-1295 formats (With and Without DAC), all tesamorelin formats (5mg and 10mg), all sermorelin formats (2mg and 5mg), GHK-CU 50mg and 100mg, MT-1 10mg, MT-2 10mg, MOTS-C 10mg and 40mg, and AOD-9604 5mg and 10mg
10.1021/acsfoodscitech.1c00301 34 NakanoM.KawasakiY.SuzukiN.TakaraT